S
Sherly Pardo
Researcher at University of Puerto Rico
Publications - 10
Citations - 1027
Sherly Pardo is an academic researcher from University of Puerto Rico. The author has contributed to research in topics: Lynch syndrome & Induced pluripotent stem cell. The author has an hindex of 7, co-authored 10 publications receiving 948 citations. Previous affiliations of Sherly Pardo include Icahn School of Medicine at Mount Sinai & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Xonia Carvajal-Vergara,Ana Sevilla,Sunita L. D’Souza,Yen-Sin Ang,Christoph Schaniel,Dung Fang Lee,Lei Yang,Aaron D. Kaplan,Eric Adler,Roye Rozov,Yongchao Ge,Ninette Cohen,Lisa Edelmann,Betty Chang,Avinash Waghray,Jie Su,Sherly Pardo,Klaske D. Lichtenbelt,Marco Tartaglia,Bruce D. Gelb,Ihor R. Lemischka +20 more
TL;DR: In vitro-derived cardiomyocytes from LEOPARD syndrome iPSCs are larger, have a higher degree of sarcomeric organization and preferential localization of NFATC4 in the nucleus when compared with cardiomeocytes derived from human embryonic stem cells or wild-type iPSC derived from a healthy brother of one of the LEopARD syndrome patients, which correlate with a potential hypertrophic state.
Journal ArticleDOI
An atypical deletion of the Williams–Beuren syndrome interval implicates genes associated with defective visuospatial processing and autism
Lisa Edelmann,Aaron Prosnitz,Sherly Pardo,Jahnavi Bhatt,Ninette Cohen,Tara L. Lauriat,Leonid Ouchanov,Patricia Jiménez González,Elina R Manghi,Pamela Bondy,Marcela Esquivel,Silvia Monge,Marietha Fallas Delgado,Alessandra Splendore,Uta Francke,Barbara K. Burton,L. Alison McInnes +16 more
TL;DR: Hemizygosity of the GTF2 family of transcription factors is sufficient to produce many aspects of the WBS CBP, and particularly implicate theGTF2 transcription factors in the visuospatial construction deficit.
Journal ArticleDOI
Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia
Sonia Mulero-Navarro,Ana Sevilla,Angel Carlos Roman,Dung Fang Lee,Sunita L. D’Souza,Sherly Pardo,Ilan Riess,Jie Su,Ninette Cohen,Christoph Schaniel,Nelson A. Rodriguez,Alessia Baccarini,Brian D. Brown,Hélène Cavé,Aurélie Caye,Marion Strullu,Safak Yalcin,Christopher Y. Park,Perundurai S. Dhandapany,Ge Yongchao,Lisa Edelmann,Sawsan Bahieg,Patrick Raynal,Elisabetta Flex,Marco Tartaglia,Kateri A. Moore,Ihor R. Lemischka,Bruce D. Gelb +27 more
TL;DR: It is reported that hematopoietic cells differentiated from human induced pluripotent stem cells (hiPSCs) harboring NS/JMML-causing PTPN11 mutations recapitulated JMML features and microRNA dysregulation was discovered, establishing a genotype-phenotype association for JMML and providing therapeutic targets.
Journal ArticleDOI
RAF1 mutations in childhood-onset dilated cardiomyopathy
Perundurai S. Dhandapany,Perundurai S. Dhandapany,Abdur Razzaque,Uthiralingam Muthusami,Sreejith Kunnoth,Jonathan J. Edwards,Sonia Mulero-Navarro,Ilan Riess,Sherly Pardo,Jipo Sheng,Deepa Selvi Rani,Bindhu Rani,Periyasamy Govindaraj,Elisabetta Flex,Tomohiro Yokota,Michiko Furutani,Tsutomu Nishizawa,Toshio Nakanishi,Jeffrey Robbins,Giuseppe Limongelli,Roger J. Hajjar,Djamel Lebeche,Ajay Bahl,Madhu Khullar,Andiappan Rathinavel,Kirsten C. Sadler,Marco Tartaglia,Rumiko Matsuoka,Kumarasamy Thangaraj,Bruce D. Gelb,Bruce D. Gelb +30 more
TL;DR: Biochemical studies showed that DCM-associated RAF1 mutants had altered kinase activity, resulting in largely unaltered ERK activation but in AKT that was hyperactivated in a BRAF-dependent manner, which resulted in a heart failure phenotype with AKT hyperactivation that was rescued by treatment with rapamycin.
Journal ArticleDOI
Clinical Cancer Genetics Disparities among Latinos.
Marcia Cruz-Correa,Julyann Pérez-Mayoral,Julie Dutil,Miguel Echenique,Rafael Mosquera,Keila Rivera-Román,Sharee Umpierre,Segundo Rodriguez-Quilichini,Maria Gonzalez-Pons,Myrta I. Olivera,Sherly Pardo +10 more
TL;DR: The status of clinical genetic cancer services for both US Latinos and those Latinos living in Latin America are discussed, including barriers to genetic testing and alternatives for providing better access to genetic services.